HomeOvarian CancerSurvival

Survival

Survival

Ovarian cancer treatment with PARP inhibitors after recurrence

Dr Steve Vasilev MD - April 3, 2021

Ovarian Cancer

Most breast and ovarian cancer patients not undergoing genetic testing study finds

Dr Steve Vasilev MD - March 3, 2021

Survival

Antibody immunity found in ovarian cancer

Dr Steve Vasilev MD - February 6, 2021

Survival

Oxford ovarian cancer classification system: predicting survival outcomes

Dr Steve Vasilev MD - January 27, 2021

Survival

ARID1A molecular driver of some ovarian cancers and glutamine benefits and harm

Dr Steve Vasilev MD - January 26, 2021

Survival

Ovarian cancer aggressive treatment can help older patients

Dr Steve Vasilev MD - January 24, 2021 0

Survival

Impact of the COVID-19 Pandemic on Ovarian Cancer Management: Adapting to the New Normal

Dr Steve Vasilev MD - January 20, 2021 0

Survival

Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact

Dr Steve Vasilev MD - September 18, 2017 0

Most Read

Endometriosis excision surgery

April 21, 2021

How Rare is Endosalpingiosis?

April 18, 2021

Recovery for Endometriosis Surgery

April 17, 2021

Ovarian cancer treatment with PARP inhibitors after recurrence

April 3, 2021